Annual Drug Patent Expirations for ORLADEYO
Orladeyo is a drug marketed by Biocryst and is included in one NDA. There are five patents protecting this drug.
This drug has forty-eight patent family members in twenty-nine countries.
The generic ingredient in ORLADEYO is berotralstat hydrochloride. Additional details are available on the berotralstat hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
